PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 261 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,408 | -15.6% | 600 | 0.0% | 0.01% | -10.0% |
| Q2 2023 | $21,804 | -11.0% | 600 | 0.0% | 0.01% | -16.7% |
| Q1 2023 | $24,486 | +5.7% | 600 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $23,166 | -27.6% | 600 | 0.0% | 0.01% | -33.3% |
| Q3 2022 | $32,000 | -8.6% | 600 | 0.0% | 0.02% | -5.3% |
| Q2 2022 | $35,000 | -23.9% | 600 | 0.0% | 0.02% | -13.6% |
| Q1 2022 | $46,000 | +27.8% | 600 | 0.0% | 0.02% | +29.4% |
| Q4 2021 | $36,000 | +16.1% | 600 | 0.0% | 0.02% | +13.3% |
| Q3 2021 | $31,000 | -13.9% | 600 | 0.0% | 0.02% | -16.7% |
| Q2 2021 | $36,000 | -14.3% | 600 | 0.0% | 0.02% | -18.2% |
| Q1 2021 | $42,000 | +5.0% | 600 | 0.0% | 0.02% | -8.3% |
| Q4 2020 | $40,000 | +11.1% | 600 | 0.0% | 0.02% | 0.0% |
| Q3 2020 | $36,000 | +12.5% | 600 | 0.0% | 0.02% | +14.3% |
| Q2 2020 | $32,000 | +60.0% | 600 | 0.0% | 0.02% | +31.2% |
| Q1 2020 | $20,000 | -23.1% | 600 | 0.0% | 0.02% | -5.9% |
| Q4 2019 | $26,000 | +13.0% | 600 | 0.0% | 0.02% | +6.2% |
| Q3 2019 | $23,000 | -11.5% | 600 | 0.0% | 0.02% | -11.1% |
| Q2 2019 | $26,000 | +8.3% | 600 | 0.0% | 0.02% | +12.5% |
| Q1 2019 | $24,000 | -7.7% | 600 | 0.0% | 0.02% | -20.0% |
| Q4 2018 | $26,000 | -10.3% | 600 | 0.0% | 0.02% | 0.0% |
| Q3 2018 | $29,000 | – | 600 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |